Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 27.24%2.42B | -1.65%3.29B | 17.96%1.9B | 66.64%3.34B | 94.95%1.61B | 66.86%2.01B | 14.50%826.95M | 36.30%1.2B | 121.61%722.2M | 4.83%882.33M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -13.66%-65.47M | -21.23%-127.79M | -11.99%-57.6M | -49.02%-105.42M | -74.27%-51.43M | 14.55%-70.74M | 12.20%-29.51M | 26.61%-82.78M | 41.31%-33.61M | -120.48%-112.79M |
| Attributable subsidiary (profit) loss | -115.22%-28K | 234.27%192K | 211.52%184K | -175.66%-143K | ---165K | --189K | ---- | ---- | ---- | ---- |
| Impairment and provisions: | -51.07%28.79M | -18.90%28.92M | 136.45%58.84M | 420.97%35.66M | 42.32%24.88M | -103.72%-11.11M | -83.44%17.49M | 319.48%298.56M | 2,908.67%105.58M | 670.04%71.18M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -356.60%-5.56M | ---- | --2.17M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | -54.55%2.82M | -136.95%-15.96M | --6.21M | 2,866.69%43.19M | ---- | -177.93%-1.56M | ---- | -61.94%2M | ---- | -40.36%5.26M |
| -Other impairments and provisions | -50.66%25.97M | 2,387.46%44.88M | 111.48%52.62M | 83.26%-1.96M | 42.32%24.88M | -103.95%-11.72M | -83.44%17.49M | 349.93%296.56M | 5,210.76%105.58M | 15,668.42%65.91M |
| Revaluation surplus: | -3.05%-72.97M | -842.25%-92.03M | -16.14%-70.82M | 132.86%12.4M | -19,697.08%-60.98M | -364.66%-37.73M | -104.75%-308K | -102.56%-8.12M | -97.17%6.49M | 77.35%317.75M |
| -Derivative financial instruments fair value (increase) | -3.05%-72.97M | -842.25%-92.03M | -192.25%-70.82M | 132.86%12.4M | -7,767.21%-24.23M | -364.66%-37.73M | -104.43%-308K | -102.56%-8.12M | -96.97%6.96M | 188.56%317.75M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---36.74M | ---- | ---- | ---- | ---470K | ---- |
| Asset sale loss (gain): | -182.77%-82.53M | 9.87%-62.23M | -1,352.58%-29.19M | -408.32%-69.05M | -16.87%2.33M | -511.48%-13.58M | -83.57%2.8M | 107.58%3.3M | 145.30%17.06M | 76.60%-43.54M |
| -Loss (gain) on sale of property, machinery and equipment | -1,813.38%-7.56M | 15.28%4.27M | -81.07%441K | -15.65%3.7M | -16.87%2.33M | 32.99%4.39M | -83.57%2.8M | 107.58%3.3M | 145.30%17.06M | -402.10%-43.54M |
| -Loss (gain) from selling other assets | -153.06%-74.97M | 8.59%-66.5M | ---29.63M | -304.76%-72.75M | ---- | ---17.97M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 2.16%311.67M | 8.82%615.55M | 0.72%305.07M | 2.39%565.65M | 3.65%302.9M | -11.02%552.43M | -3.31%292.24M | 1.04%620.86M | -0.20%302.26M | -9.07%614.47M |
| -Amortization of intangible assets | 16.07%10.18M | 11.69%19.49M | 0.07%8.77M | -10.47%17.45M | 3.35%8.77M | 17.27%19.49M | 33.74%8.48M | 30.73%16.62M | 2.70%6.34M | 0.83%12.71M |
| Financial expense | -17.38%20.8M | -47.74%34.96M | -35.02%25.17M | -18.01%66.9M | 77.67%38.74M | 35.47%81.6M | -32.63%21.8M | -66.77%60.23M | -74.53%32.36M | -35.45%181.27M |
| Unrealized exchange loss (gain) | 500.46%36.76M | 100.67%74K | 30.59%-9.18M | -122.26%-10.97M | -118.49%-13.23M | 179.41%49.3M | 402.70%71.52M | 39.28%-62.08M | -749.42%-23.63M | -282.01%-102.24M |
| Special items | -45.26%57.29M | 74.02%55.77M | 95.42%104.66M | -47.23%32.05M | 349.41%53.56M | 1,025.65%60.73M | 250.16%11.92M | 138.04%5.4M | -47.40%-7.94M | -5.22%-14.18M |
| Operating profit before the change of operating capital | 19.07%2.65B | -3.33%3.74B | 16.77%2.23B | 47.88%3.87B | 57.11%1.91B | 28.45%2.62B | 8.40%1.21B | 13.59%2.04B | 26.69%1.12B | 0.12%1.79B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -139.18%-344.26M | -52.25%-179.72M | -332.20%-143.93M | 25.30%-118.05M | 84.52%-33.3M | 72.64%-158.04M | 2.81%-215.18M | -508.23%-577.53M | -634.50%-221.4M | 218.49%141.47M |
| Accounts receivable (increase)decrease | -64.73%488.11M | 127.47%429.08M | 223.28%1.38B | -298.30%-1.56B | -422.88%-1.12B | 54.41%-392.22M | 42.64%-214.7M | -71.90%-860.37M | ---374.28M | -269.65%-500.5M |
| Accounts payable increase (decrease) | 75.38%-310.72M | -114.53%-115.15M | -268.72%-1.26B | 232.42%792.37M | 1,749.41%747.96M | -79.27%238.36M | -91.87%40.44M | 328.53%1.15B | 304.80%497.48M | 30,805.76%268.26M |
| Special items for working capital changes | -3,230.17%-29.05M | -15.17%-19.47M | 103.03%928K | -169.18%-16.9M | -63.37%-30.64M | -18.10%24.43M | -178.34%-18.76M | 62.19%29.83M | -216.55%-6.74M | 311.26%18.39M |
| Cash from business operations | 11.33%2.46B | 30.02%3.86B | 50.18%2.21B | 27.29%2.97B | 82.24%1.47B | 30.96%2.33B | -20.59%806.71M | 3.35%1.78B | 28.39%1.02B | -12.15%1.72B |
| Other taxs | -27.21%-460.92M | -24.81%-657.74M | -32.87%-362.33M | -75.75%-526.99M | -85.30%-272.68M | -26.54%-299.85M | 1.71%-147.16M | -53.83%-236.97M | -37.02%-149.71M | 2.95%-154.05M |
| Net cash from operations | 8.21%2B | 31.15%3.2B | 54.12%1.85B | 20.14%2.44B | 81.56%1.2B | 31.64%2.03B | -23.85%659.55M | -1.61%1.54B | 27.00%866.11M | -12.96%1.57B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 13.66%65.47M | 21.23%127.79M | 11.99%57.6M | 49.02%105.42M | 74.27%51.43M | 37.10%70.74M | 76.58%29.51M | 25.55%51.59M | -17.39%16.71M | -19.67%41.09M |
| Decrease in deposits (increase) | 23.09%252.54M | 77.62%-62.12M | 908.27%205.17M | -309.18%-277.55M | -89.21%20.35M | 134.27%132.69M | 221.55%188.54M | -232.47%-387.2M | -171.80%-155.12M | 289.81%292.28M |
| Sale of fixed assets | 1,130.76%20.73M | 117.86%9.51M | -25.09%1.68M | -42.43%4.37M | 792.06%2.25M | -60.42%7.59M | -91.95%252K | -68.84%19.16M | -93.01%3.13M | 733.33%61.5M |
| Purchase of fixed assets | -115.67%-1.68B | -34.58%-1.72B | -65.78%-779.15M | -63.49%-1.27B | -47.65%-470M | -61.68%-779.55M | 8.82%-318.32M | 9.15%-482.17M | -98.17%-349.12M | -23.03%-530.76M |
| Purchase of intangible assets | -20.37%-46.47M | 17.25%-155.11M | -7,698.99%-38.61M | -381.74%-187.45M | 98.06%-495K | -653.51%-38.91M | -1,039.48%-25.51M | 24.23%-5.16M | ---2.24M | 61.06%-6.82M |
| Recovery of cash from investments | 88.60%20.14B | ---- | 233.42%10.68B | ---- | --3.2B | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | -88.42%-20.07B | -780.00%-20.82B | -234.05%-10.65B | -39.86%-2.37B | ---3.19B | ---1.69B | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | 756.49%20.89B | ---- | 43.10%2.44B | ---- | 686.92%1.7B | ---- | -30.02%216.55M | 17.90%118.03M | 178.51%309.45M |
| Net cash from investment operations | -150.76%-1.31B | -10.99%-1.73B | -37.25%-523.67M | -161.71%-1.56B | -203.96%-381.56M | -1.31%-594.92M | 65.95%-125.53M | -452.14%-587.22M | -279.83%-368.6M | 138.49%166.76M |
| Net cash before financing | -48.26%683.95M | 66.71%1.47B | 62.02%1.32B | -38.53%882.49M | 52.79%815.91M | 50.28%1.44B | 7.34%534.03M | -44.92%955.33M | -43.91%497.51M | 26.80%1.73B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 182.66%3.02B | 8.98%2.23B | -14.02%1.07B | -30.75%2.04B | 44.42%1.24B | 111.70%2.95B | 52.57%861.36M | -42.05%1.39B | -74.98%564.56M | -35.53%2.41B |
| Refund | -727.30%-1.05B | 78.91%-586.14M | 93.74%-127M | -5.91%-2.78B | -221.59%-2.03B | -53.50%-2.62B | -26.53%-631.36M | 57.91%-1.71B | 84.11%-498.97M | -36.04%-4.06B |
| Interest paid - financing | -31.38%-41.61M | 12.79%-68.4M | 22.06%-31.67M | -3.72%-78.43M | -138.93%-40.64M | -49.86%-75.62M | 49.28%-17.01M | 59.36%-50.46M | 63.58%-33.53M | 42.45%-124.16M |
| Dividends paid - financing | ---- | -75.00%-1.02B | ---- | -113.27%-581.45M | ---- | -23.45%-272.64M | ---- | -72.35%-220.85M | ---- | -30.25%-128.14M |
| Absorb investment income | ---- | 200.00%36M | --36M | 500.00%12M | ---- | --2M | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---36.58M | ---- | ---- | ---- | -2.80%-42.29M | ---40.69M | ---41.14M | ---- | ---- |
| Other items of the financing business | 180.27%72.97M | 95.81%47.25M | 82.56%26.04M | -39.91%24.13M | 900.84%14.26M | 329.15%40.16M | --1.43M | 551.74%9.36M | ---- | --1.44M |
| Net cash from financing operations | 106.26%2B | 143.80%596.91M | 219.10%970.37M | -5,538.82%-1.36B | -574.38%-814.74M | 96.11%-24.17M | 450.88%171.75M | 67.45%-620.93M | 103.19%31.18M | -700.38%-1.91B |
| Effect of rate | -235.40%-765K | 70.07%-267K | -5.36%565K | -247.68%-892K | -49.15%597K | 411.34%604K | 75.22%1.17M | -103.88%-194K | 20.29%670K | 282.04%5M |
| Net Cash | 17.15%2.69B | 530.69%2.07B | 195,153.49%2.29B | -134.02%-480.19M | -99.83%1.17M | 322.09%1.41B | 33.50%705.77M | 293.28%334.4M | 689.42%528.69M | -110.26%-173.01M |
| Begining period cash | 48.52%6.33B | -10.14%4.26B | -10.14%4.26B | 42.39%4.74B | 42.39%4.74B | 11.15%3.33B | 11.15%3.33B | -5.31%3B | -5.31%3B | 113.57%3.16B |
| Cash at the end | 37.52%9.01B | 48.52%6.33B | 38.15%6.55B | -10.14%4.26B | 17.51%4.74B | 42.39%4.74B | 14.51%4.04B | 11.15%3.33B | 14.65%3.53B | -5.31%3B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.